CureVac sues BioNTech, claiming Covid-19 vaccine infringes key mRNA patents
Messenger RNA vaccine biotech CureVac is suing BioNTech, alleging that its rival’s Covid-19 vaccine infringes on intellectual property built on more than two decades of […]
Messenger RNA vaccine biotech CureVac is suing BioNTech, alleging that its rival’s Covid-19 vaccine infringes on intellectual property built on more than two decades of […]
President Biden on Monday announced a fifth mission to bring infant formula to the U.S. from overseas, with the most recent shipment arriving from Cologne, […]
Bayer is committing another €1.3 billion to Leaps by Bayer, the company’s investment arm, to support additional investments in companies developing innovative technologies in healthcare […]
MorphoSys is cutting the drug discovery and R&D work of Constellation Pharmaceuticals, a company it acquired lats year in a $1.7 billion deal. This consolidation […]
BioNTech is acquiring a preclinical T cell receptor program (TCR) from Medigene, as well as licenses to the biotech’s TCR technologies. The agreement helps BioNTech […]
Two of the three parties in Germany’s new governing coalition support legalization, a potentially radical shift in the conservative country.
Pfizer is paying BioNTech $225 million to kick off a new alliance aiming to develop a shingles vaccine based on the same messenger RNA technology […]
Two of the three parties in Germany’s new governing coalition support legalization, a potentially radical shift in the conservative country.
German city where early Covid vaccine was developed uses its new-found wealth to slash debt and attract other biotech firms The Pfizer/BioNTech jab is having […]
Bristol Myers Squibb is paying $150 million up front for global rights to an Immatics biologic drug designed to recruit a patient’s T cells to […]
Fact boxes can quantify benefits and harms in a clear and accessible format. When it comes to cancer screening, doctors “have too often ignored” the […]
Preliminary data suggest the BioNTech and Pfizer Covid-19 vaccine may have diminished protection against the omicron variant, but that levels of neutralizing antibodies can be […]
Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine Comirnaty, saying it seems less likely to […]
Evotec is an old player in the life sciences, but in offering new shares on the Nasdaq, the Germany-based company plans to bolster its new […]
Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus […]
Full FDA approval makes the Pfizer/BioNTech Covid-19 vaccine the first to reach that milestone. But the regulatory decision also flagged a potential risk of heart […]
Citing a lack of scientific evidence, the W.H.O. argues that extra vaccine doses should be sent to poor countries instead.
Germany’s health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the […]
A Covid-19 vaccine candidate based on messenger RNA technology from CureVac is showing 47% efficacy according to an interim analysis of a pivotal study. The […]
The Covid-19 pandemic pushed healthcare workers to their breaking point worldwide. In Western Europe, hospitals responded by offering free counseling and sharing videos on meditation […]
G7 summit hears move would slash the cost of jabs and accelerate the rollout of programmes across the developing world Britain and Germany were last […]
MorphoSys is acquiring Constellation Pharmaceuticals and its late-stage myelofibrosis drug in a deal that values the epigenetics biotech at $1.7 billion. Germany-based MorphoSys will finance […]
Leaps by Bayer led a $90 million investment round into Ada, a German digital health startup with an AI-based symptom checker. As part of the […]
Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on […]
Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims to private health insurers. Now, the startup […]
Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our […]
We asked eight people from around the world what they thought about American health care. It didn’t go well.
We asked eight people from around the world what they thought about American health care. It didn’t go well.
We asked eight people from around the world what they thought about American health care. It didn’t go well.
European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage […]
Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. […]
Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in […]
Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates Coronavirus – latest updates See all […]
The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone […]
The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to […]
Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our […]
Government to work with German firm CureVac on tackling potential mutations Coronavirus – latest updates See all our coronavirus coverage The UK government has signed […]
EMD Serono’s Tepmetko is one of a number of targeted cancer therapies that have passed FDA muster in the past year. The decision sets up […]
Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to […]
In this first article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discuss the role that disease rarity plays in […]
Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK Coronavirus – latest updates See all our […]
European commission says new mechanism will give national regulators power to refuse exports Coronavirus – latest updates See all our coronavirus coverage Millions of doses […]
Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery […]
Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery […]
Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery […]
Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65 The German government has challenged […]
Country will be first in EU to use antibody cocktails after government buys 200,000 doses Specialist clinics in Germany will this week become the first […]
Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus […]
Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech […]
Chief executive, Uğur Şahin, says team will know within two weeks if vaccine works or needs adaption Coronavirus – latest updates See all our coronavirus […]
Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the […]
Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The […]
Exclusive: Ugur Şahin says he and Pfizer CEO received results night before announcement Coronavirus – latest updates See all our coronavirus coverage The scientist behind […]
Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’ Coronavirus – latest updates See all our coronavirus […]
The news sent the stock market soaring as it represents a key milestone in developing and distributing a vaccine for the virus. Still public confidence […]
Interim trial results are encouraging as scientists welcome news Coronavirus – latest updates See all our coronavirus coverage It is not yet the end of […]
Couple who set up and run firm are children of long-maligned ‘guest workers’ from Turkey Coronavirus – latest updates See all our coronavirus coverage When […]
A review published in JAMA found that bills introduced into the House and Senate don’t go nearly as far as existing drug pricing regulations other […]
Shots: The companies launch Nepexto, a biosimilar referencing Amgen’s Enbrel, and is indicated for the mod. to sev. RA, JIA from the age of 2yrs., […]
The companies also said their Phase II/III study, slated to enroll about 30,000 participants, had already dosed more than 11,000.
KaNDy’s lead product candidate, NT-814, is a non-hormonal treatment for symptoms of menopause. The drug completed Phase IIb testing and is slated to start Phase […]
New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always […]
The FDA approved Monjuvi for second-line diffuse large B-cell lymphoma. Though the drug has the same antigen target as approved CAR-T cell therapies, it is […]
Shots: The companies reported that most advanced of four COVID-19 vaccine candidates from their BNT162 mRNA-based vaccine program demonstrated the ability to elicit high SARS-CoV-2 […]
Stake of 10% in CureVac is part of deal that could eventually be worth more than £800m Coronavirus – latest updates See all our coronavirus […]
Tea consumption is associated with a reduced risk of heart disease, stroke, and premature death in general, with each additional cup of green tea a […]
Copyright © 2024 | WordPress Theme by MH Themes